Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis

被引：0
|
作者：
Mao-Lu Tian
Yan Shen
Zhao-Lin Sun
Yan Zha
机构：
[1] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Nephrology
[2] Guizhou Provincial People’s Hospital,Institute of Nephritic and Urinary Disease, Department of Urology
来源：
International Urology and Nephrology | 2015年 / 47卷
关键词：
Diabetic nephropathy; Pentoxifylline; Angiotensin-converting enzyme inhibitors; Angiotensin receptor blockers; Randomized controlled trails;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：815 / 822
页数：7
相关论文
共 50 条
  • [1] Efficacy and safety of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in diabetic nephropathy: a meta-analysis
    Tian, Mao-Lu
    Shen, Yan
    Sun, Zhao-Lin
    Zha, Yan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2015, 47 (05) : 815 - 822
  • [2] Efficacy and safety of angiotensin-converting enzyme inhibitors/angiotensin receptor blocker therapy for IgA nephropathy: A meta-analysis of randomized controlled trials
    Ji, Yue
    Yang, Kang
    Xiao, Bo
    Lin, Jin
    Zhao, Qingyun
    Bhuva, Maheshkumar Satishkumar
    Yang, Hongtao
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2019, 120 (03) : 3689 - 3695
  • [3] Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Lai, Chun-Fu
    Wu, VinCent
    Chiang, Wen-Chih
    Chen, Yung-Ming
    Wu, Kwan-Dun
    Tsai, Tun-Jun
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2014, 113 (04) : 219 - 226
  • [4] Efficacy and safety of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers in diabetic nephropathy: a systematic review and meta-analysis
    Du, Yuan-Hong
    Guan, Cheng-Jing
    Li, Lin-Yu
    Gan, Ping
    ANNALS OF PALLIATIVE MEDICINE, 2022, 11 (03) : 1093 - 1101
  • [5] The Efficacy of Angiotensin Receptor-Neprilysin Inhibitor Versus Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Post Myocardial Infarction: A Meta-Analysis
    Kotak, Sohny
    Hassan, Warda
    Mehmood, Marium
    Kumar, Umesh
    Sagreeka, Fnu
    Karishma, Fnu
    Kumari, Pirya
    Pirya, Fnu
    Saquib, Javeria
    Iqbal, Amna
    Khan, Anosh Aslam
    Varrassi, Giustino
    Khatri, Mahima
    Kumar, Satesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (10)
  • [6] The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy
    Sen, Saniye
    Ustundag, Sedat
    Gonlusen, Gulfiliz
    Kanter, Mehmet
    Dogutan, Haluk
    Ciftci, Senturk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 53 - 53
  • [7] Therapeutic perspective: starting an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in a diabetic patient
    Jarred, Ghassan
    Kennedy, R. Lee
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2010, 1 (01) : 23 - 28
  • [8] Reply to comment on "Renoprotective effect of combining pentoxifylline with angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker in advanced chronic kidney disease"
    Chen, Ping-Min
    Lai, Tai-Shuan
    Chen, Ping-Yu
    Chiang, Wen-Chih
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2015, 114 (01) : 95 - 96
  • [9] The effect of combining angiotensin receptor blocker and angiotensin converting enzyme inhibitor on albuminuria in Type 2 diabetic patients with nephropathy
    Tan, F
    Liew, S
    Mukherjee, JJ
    Lee, KO
    Lim, P
    DIABETOLOGIA, 2004, 47 : A386 - A386
  • [10] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60
12345